Immunoglobulin a nephropathy Trials in Seville, Spain
Conditions / Immunoglobulin a nephropathy / Seville, Spain
Immunoglobulin a nephropathy has been the subject of sustained clinical investigation across multiple research sites.
12 total trials for this combination
Showing top 10 of 12 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04573478 | Atrasentan in Patients With IgA Nephropathy | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT04287985 | Safety and Efficacy Study of VIS649 for IgA Nephropathy | COMPLETED | — |
| NCT05852938 | A Study of Zigakibart in Adults With IgA Nephropathy | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT04287985 | Safety and Efficacy Study of VIS649 for IgA Nephropathy | COMPLETED | — |
| NCT06564142 | Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT05248646 | Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT05003986 | Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases | RECRUITING | PHASE2 |
| NCT03762850 | A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT04564339 | Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) | TERMINATED | PHASE2 |
| NCT06291376 | Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN) | RECRUITING | — |